Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2025-12-24 @ 6:33 PM
NCT ID:
NCT01592357
Eligibility Criteria:
Inclusion Criteria:
1. Walking Speed \< or = 1.3 m/sec during the gait speed assessment.
2. Evidence of cardiovascular disease based on a diagnosis of previous myocardial infarction, angiographic findings of coronary artery disease, previous percutaneous coronary intervention, or previous coronary artery bypass graft surgery.
3. Local resident, with available transportation to the Cardiac Health and Rehabilitation Centre (CHRC) at the Hamilton Health Sciences General Division.
4. Ability to understand written and verbal instructions and provide written informed consent.
5. Stable cardiac medical therapy as demonstrated by no change in medication during the 3 months prior to randomization.
6. Previous completion of the 6 month Cardiac Rehabilitation program (including exercise training component) at the CHRC.
Exclusion Criteria:
1. New York Heart Association Functional class IV symptoms of shortness of breath or angina.
2. Development of angina or ST segment depression of \> 1 mm during symptom limited exercise testing at \< 80% of predicted maximum power output.
3. Development of dysrhythmias during exercise (\> Lown grade 2).
4. Resting blood pressure greater than 160 mmHg systolic or 90 mmHg diastolic.
5. Abnormal blood pressure response to clinical exercise testing (decrease in systolic pressure below resting; decrease of \> 20 mmHg in systolic pressure after the normal exercise increase; rise in diastolic blood pressure of \> 15 mmHg; maximal systolic blood pressure in excess of 250 mmHg).
6. Maximum heart rate \< 100 beats per minute in the absence of beta blocker therapy.
7. Respiratory limitation as assessed by pre-exercise pulmonary function testing (documented restrictive or obstructive lung disease; based on forced expired volume in 1 sec and/or vital capacity measurements \< 70% of predicted).
8. Major orthopedic disability.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT01592357
Study Brief:
Protocol Section:
NCT01592357